Objective To investigate the influence of ideal cardiovascular health behaviors and factors on the onset of primary liver cancer in northern China. Methods A prospective cohort study was conducted for 95 055 on-the-job or retired employees of Kailuan Group who underwent physical examination from July 2006 to June 2007,and related data were collected. They were followed up to observe the onset of primary liver cancer. According to the cardiovascular health score( CHS),the subjects were divided into first quartile group with 27 143 subjects( CHS≤7),second quartile group with 35 488 subjects( 7 < CHS≤9),and third quartile group with 32 424 subjects( 9 < CHS≤14),and the person-year incidence rate was calculated. A one-way analysis of variance was used for comparison of normally distributed continuous data between multiple groups,and the Kruskal-Wallis H test was used for comparison of continuous data with skewed distribution between multiple groups. The chi-square test was used for comparison of categorical data between groups. The life-table method was used to calculate the cumulative incidence rate of primary liver cancer,and the log-rank test was used for comparison of cumulative incidence rate between groups. The Cox proportional hazards model was used to analyze the influence of ideal cardiovascular health behaviors and factors on the onset of primary liver cancer. Results There were significant differences between the three groups in age,male/female ratio,body mass index,total cholesterol,fasting blood glucose,alanine aminotransferase,hypersensitive C-reactive protein,drinking,family income,educational level,fatty liver disease,family history of cancer,and proportion of subjects with ideal smoking,ideal physical exercise,ideal body mass index,ideal blood pressure,ideal total cholesterol,ideal blood glucose,and ideal diet ratio( all P < 0. 05). The mean follow-up time was 11. 49 ± 1. 86 years,and a total of 387 cases of primary liver cancer were observed,among whom there were 360 male and 27 female patients. The person-year incidence rates of the three groups were 4. 11/10 000 person-years,3. 78/10 000 person-years,and 2. 84/10 000 person-years,respectively. The 10-year cumulative incidence rates of the three groups were 4. 43‰,3. 61‰,and 2. 84‰,respectively,and there was a significant difference in the cumulative incidence rate between the three groups( χ2= 8. 29,P =0. 016). The Cox proportional hazards model showed that after adjustment for confounding factors( age,sex,alanine aminotransferase,hypersensitive C-reactive protein,drinking,family income,educational level,positive HBs Ag,liver cirrhosis,fatty liver disease,and family history of cancer),compared with the first quartile group,the second quartile group had a hazard ratio( HR) of 0. 87( 95% confidence interval [CI]: 0. 67-1. 13) and the third quartile group had an HR of 0. 74( 95% CI: 0. 56-0. 98)( P for trend < 0. 05). Conclusion The higher scores of ideal cardiovascular health behaviors and factors play a protective role in the onset of primary liver cancer,and the risk of primary liver cancer decreases with the increase in cardiovascular score.
[1] FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al. Cancer incidence and mortality worldwide:Sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer,2015,136(5):e359-e386.
|
[2] Prevention of Infection Related Cancer(PIRCA)Group,Specialized Committee of Cancer Prevention and Control,Chinese Preventive Medicine Association; Non-communicable&Chronic Disease Control and Prevention Society,Chinese Preventive Medicine Association; Health Communication Society,Chinese Preventive Medicine Association. Strategies of primary prevention of liver cancer in China:Expert Consensus(2018)[J]. J Clin Hepatol,2018,34(10):2090-2097.(in Chinese)中华预防医学会肿瘤预防与控制专业委员会感染相关肿瘤防控学组,中华预防医学会慢病预防与控制分会,中华预防医学会健康传播分会.中国肝癌一级预防专家共识(2018)[J].临床肝胆病杂志,2018,34(10):2090-2097.
|
[3] ZHU NB,ZHOU M,YU CQ,et al. Prevalence of‘healthy lifestyle’in Chinese adults[J]. Chin J Epidemiol,2019,40(2):136-141.(in Chinese)祝楠波,周密,余灿清,等.中国成年人健康生活方式状况分析[J].中华流行病学杂志,2019,40(2):136-141.
|
[4] YANG WS,GAO J,GAO S,et al. A prospective study on cigarette smoking and liver cancer risk:A Meta-analysis[J].Tumor,2010,30(3):247-252.(in Chinese)杨万水,高静,高姗,等.吸烟与肝癌前瞻性研究的荟萃分析[J].肿瘤,2010,30(3):247-252.
|
[5] TURATI F,GALEONE C,ROTA M,et al. Alcohol and liver cancer:A systematic review and meta-analysis of prospective studies[J]. Ann Oncol,2014,25(8):1526-1535.
|
[6] SUNG H,SIEGEL RL,TORRE LA,et al. Global patterns in excess body weight and the associated cancer burden[J]. CA Cancer J Clin,2019,69(2):88-112.
|
[7] MA Y,YANG W,SIMON TG,et al. Dietary patterns and risk of hepatocellular carcinoma among U. S. men and women[J].Hepatology,2019,70(2):577-586.
|
[8] KERR J,ANDERSON C,LIPPMAN SM. Physical activity,sedentary behaviour,diet,and cancer:An update and emerging new evidence[J]. Lancet Oncol,2017,18(8):e457-e471.
|
[9] WILD SH,WALKER JJ,MORLING JR,et al. Cardiovascular disease,cancer,and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission[J]. Diabetes Care,2018,41(2):341-347.
|
[10] LIU Y,WARREN ANDERSEN S,WEN W,et al. Prospective cohort study of general and central obesity,weight change trajectory and risk of major cancers among Chinese women[J]. Int J Cancer,2016,139(7):1461-1470.
|
[11] McCORMACK VA,BOFFETTA P. Today’s lifestyles,tomorrow’s cancers:Trends in lifestyle risk factors for cancer in low-and middle-income countries[J]. Ann Oncol,2011,22(11):2349-2357.
|
[12] LLOYD-JONES DM,HONG Y,LABARTHE D,et al. Defining and setting national goals for cardiovascular health promotion and disease reduction:The American Heart Association’s strategic Impact Goal through 2020 and beyond[J]. Circulation,2010,121(4):586-613.
|
[13] WANG YX,WU SL,GAO JS,et al. Relationship between ideal cardiovascular health behaviors and factors with new-onset ischemic stroke[J]. Chin J Hypertension,2012,20(4):342-346.(in Chinese)王艳秀,吴寿岭,高竞生,等.理想心血管健康行为和因素对新发缺血性脑卒中的影响[J].中华高血压杂志,2012,20(4):342-346.
|
[14] ZHANG CF,SHI JH,HUANG Z,et al. Relationship between‘ideal’ cardiovascular behaviors and factors and the incidence of hypertension[J]. Chin J Epidemiol,2014,35(5):494-499.(in Chinese)张彩凤,施继红,黄喆,等.理想心血管健康行为和因素对新发高血压的影响[J].中华流行病学杂志,2014,35(5):494-499.
|
[15] Ministry of Health of the People’s Republic of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J]. J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.
|
[16] HU DY,MA CS. Cardiology practice-standardized treatment(2010)[M]. Beijing:People’s Health Publishing House,2010:10-14.(in Chinese)胡大一,马长生.心脏病学实践2010—规范化治疗[M].北京:人民卫生出版社,2010:10-14.
|
[17] SUN MM,CAO LY,SUN WD,et al. Association of serum high-density lipoprotein cholesterol with new-onset cholelithiasis[J]. J Clin Hepatol,2019,35(8):1745-1750.(in Chinese)孙苗苗,曹立瀛,孙卫东,等.血清高密度脂蛋白胆固醇与新发胆石症的关系[J].临床肝胆病杂志,2019,35(8):1745-1750.
|
[18] SHI JH,HAO YH,WU SL,et al. The prevalence and distribution of ideal cardiovascular health behavior in employees of Kailuan Group cohort[J]. Chin J Cardiol,2012,40(1):62-67.(in Chinese)施继红,郝雁红,吴寿岭,等.开滦研究人群理想心血管健康行为和因素分布调查[J].中华心血管病杂志,2012,40(1):62-67.
|
[19] ZUO TT,ZHENG RS,ZENG HM,et al. Analysis of liver cancer incidence and trend in China[J]. Chin J Oncol,2015,37(9):691-696.(in Chinese)左婷婷,郑荣寿,曾红梅,等.中国肝癌发病状况与趋势分析[J].中华肿瘤杂志,2015,37(9):691-696.
|
[20] World Health Organization. World Cancer Report 2014[EB/OL]. https://www. who. int/cancer/publications/WRC_2014/en/.Accessed December 20,2018.
|
[21] RASMUSSEN-TORVIK LJ,SHAY CM,ABRAMSON JG,et al. Ideal cardiovascular health is inversely associated with incident cancer:The Atherosclerosis Risk In Communities study[J]. Circulation,2013,127(12):1270-1275.
|
[22] ALEKSANDROVA K,PISCHON T,JENAB M,et al. Combined impact of healthy lifestyle factors on colorectal cancer:A large European cohort study[J]. BMC Med,2014,12:168.
|
[23] WANG X,YANG X,LI J,et al. Impact of healthy lifestyles on cancer risk in the Chinese population[J]. Cancer,2019,125(12):2099-2106.
|
[24] Chinese Center of Disease Control and Prevention. Global Adults Tobacco Survey(GATS)China 2010 Country Report[EB/OL]. 2011. https://www. who. int/health-topics/tobacco.
|
[25] LEE YC,COHET C,YANG YC,et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer[J].Int J Epidemiol,2009,38(6):1497-1511.
|
[26] LIU X,BAECKER A,WU M,et al. Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population[J]. Int J Cancer,2018,142(8):1560-1567.
|
[27] CHUANG SC,LEE YC,HASHIBE M,et al. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer:A meta-analysis[J]. Cancer Epidemiol Biomarkers Prev,2010,19(5):1261-1268.
|
[28] STAPLIN N,HAYNES R,HERRINGTON WG,et al. Smoking and adverse outcomes in patients with CKD:The study of heart and renal protection(SHARP)[J]. Am J Kidney Dis,2016,68(3):371-380.
|
[29] BANKS E,JOSHY G,KORDA RJ,et al. Tobacco smoking and risk of 36 cardiovascular disease subtypes:Fatal and non-fatal outcomes in a large prospective Australian study[J]. BMC Med,2019,17(1):128.
|
[30] YAO KF,MA M,DING GY,et al. Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI[J]. Oncotarget,2017,8(42):72959-72971.
|
[31] TIAN Y,JIANG C,WANG M,et al. BMI,leisure-time physical activity,and physical fitness in adults in China:Results from a series of national surveys,2000-14[J]. Lancet Diabetes Endocrinol,2016,4(6):487-497.
|
[32] WANG L,GAO P,ZHANG M,et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J]. JAMA,2017,317(24):2515-2523.
|
[33] Investigation and Research Group of National Cooperative Group of Diabetes Research. Investigation report of diabetes among 300thousand people from 14 provinces and cities of China[J]. Chin J Intern Med,1981,20(11):678-683.(in Chinese)全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11):678-683.
|
[34] LIU T,LIU H,JIN PF,et al. Correlation between fasting blood glucose and hepatocarcinogenesis:A multicentre retrospective study(A report of 94 264 cases)[J]. Chin J Dig Surg,2019,18(4):348-357.(in Chinese)刘通,刘海,金鹏飞,等.空腹血糖与肝癌发病关系的多中心回顾性研究(附94264例报告)[J].中华消化外科杂志,2019,18(4):348-357.
|
[35] HAN H,ZHANG T,JIN Z,et al. Blood glucose concentration and risk of liver cancer:Systematic review and meta-analysis of prospective studies[J]. Oncotarget,2017,8(30):50164-50173.
|
[1] | Ru JIA, Pingping ZHANG, Yuan YUAN, Yiyang HU, Qin FENG. Differences and application value of plasma bile acids in tumors of the liver[J]. Journal of Clinical Hepatology, 2024, 40(10): 2042-2048. doi: 10.12449/JCH241018 |
[2] | Jianguo JIA, Xiangming MA, Fei TIAN, Yali ZHANG, Jiaying DAI, Saifang LUO, Liying CAO. Influence of triglyceride/high-density lipoprotein cholesterol ratio on the onset of primary liver cancer[J]. Journal of Clinical Hepatology, 2024, 40(4): 753-759. doi: 10.12449/JCH240418 |
[3] | Dongna ZHAO, Qian LIU, Huijie LIANG, Haozhe CUI, Lingqun MENG, Huiliang E, Liying CAO. Effect of ideal cardiovascular health metrics on the incidence rate of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(1): 124-128. doi: 10.3969/j.issn.1001-5256.2022.01.019 |
[4] | WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018 |
[5] | ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006 |
[6] | Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042 |
[7] | He YaJing, Zhang ZhiMing, He WeiMeng, Hou JinLin. Epidemiological characteristics and prognosis of hepatocellular carcinoma: A single-center observational real-world cohort study of 1302 cases[J]. Journal of Clinical Hepatology, 2019, 35(5): 1002-1007. doi: 10.3969/j.issn.1001-5256.2019.05.014 |
[8] | Ji RuiGeng, Zhu GuoLing, Zhang Bing, Sun Qiu, Zhao Li, Li GuangJian, Cao LiYing. Association between dyslipidemia and acute pancreatitis: A prospective cohort study[J]. Journal of Clinical Hepatology, 2019, 35(7): 1536-1540. doi: 10.3969/j.issn.1001-5256.2019.07.023 |
[9] | Wang ZhiYu, Gu SanWei, Chen XiaoQian, Cai YanJun. Clonorchiasis misdiagnosed as hepatic tumor: a case report[J]. Journal of Clinical Hepatology, 2018, 34(3): 602-603. doi: 10.3969/j.issn.1001-5256.2018.03.033 |
[10] | Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014 |
[11] | Hu XiaoYun, Sun Jian. Long-term follow-up cohort of hepatitis B in China: current status and perspectives[J]. Journal of Clinical Hepatology, 2017, 33(8): 1454-1457. doi: 10.3969/j.issn.1001-5256.2017.08.008 |
[12] | Wang JinWei, Zhang YaMin. Research advances in methods for determination of tumor boundary in hepatectomy[J]. Journal of Clinical Hepatology, 2016, 32(2): 374-377. doi: 10.3969/j.issn.1001-5256.2016.02.039 |
[13] | Wang WuChen, Zhou YongNing. Research progress in tumor- associated antigen antibodies for diagnosis of liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(6): 573-576. doi: 10.3969/j.issn.1001-5256.2014.06.025 |
[14] | Fang ZiYan, Huang Long, Li Gong. Research progress in radiotherapy for liver tumors reported in 2013 ASTRO Annual Meeting[J]. Journal of Clinical Hepatology, 2014, 30(4): 383-385. doi: 10.3969/j.issn.1001-5256.2014.04.025 |
[15] | Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001 |
[16] | Chen Hong, Wang Zhi, Wu Jian. Circulating tumor cells of hepatocellular carcinoma and their clinical implications[J]. Journal of Clinical Hepatology, 2011, 27(8): 796-800. |
[18] | Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365. |
1. | 王巍博. 64排螺旋CT后处理技术在原发性肝癌术前分期评估中的应用价值. 中西医结合肝病杂志. 2023(06): 536-539+545 . ![]() | |
2. | 徐红霞,张秀娟. 心理分级模式的干预对腹腔镜肝脏手术患者负面情绪及应激反应的影响. 中国健康心理学杂志. 2023(11): 1681-1685 . ![]() | |
3. | 兰芳,汪旅州,张红. 全媒体健康教育在原发性肝癌患者中的应用. 中国肿瘤临床与康复. 2022(03): 369-371 . ![]() | |
4. | 袁珊. 综合康复护理对肝癌合并心血管疾病患者接受肝动脉灌注化疗栓塞术的术后康复效果分析. 中西医结合心血管病电子杂志. 2021(13): 30-32+26 . ![]() | |
5. | 陶明,刘倩,崔皓哲,刘希宁,王一鸣,刘四清,曹立瀛. BMI纵向轨迹对新发胆石症的影响. 临床肝胆病杂志. 2020(11): 2500-2504 . ![]() |